Timboligue, Bernadette M.

HRN: 28-56-04  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/10/2026
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
03/10/2026
03/17/2026
IV
100mg
OD
Oral Candidiasis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines